Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Assets (2022 - 2025)

Gossamer Bio's Non-Current Assets history spans 4 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 14.79% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $19.6 million, up 4.96%, while the annual FY2025 figure was $4.6 million, 14.79% down from the prior year.
  • Non-Current Assets reached $4.6 million in Q4 2025 per GOSS's latest filing, down from $4.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $13.9 million in Q1 2022 to a low of $2.5 million in Q2 2024.
  • Average Non-Current Assets over 4 years is $7.3 million, with a median of $5.9 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: tumbled 69.59% in 2024, then surged 97.52% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $10.6 million in 2022, then tumbled by 48.94% to $5.4 million in 2023, then rose by 0.13% to $5.4 million in 2024, then dropped by 14.79% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Non-Current Assets are $4.6 million (Q4 2025), $4.8 million (Q3 2025), and $5.0 million (Q2 2025).